Archive for November 30th, 2008

source: The Botswana Gazette

Public concerns about the motive behind establishing the Directorate of Intelligence and Security Services will not be allayed by speculation that it is largely a Botswana Democratic apparatus, headed by a President Khama loyalist and overseen by a trio of BDP activists.

It is extremely worrying that a large part of our society will increasingly feel that national resources are being hijacked by a small elite group to use them for their own benefit and for the benefit of persons who are close to them.

There can be no greater danger in a country than a partisan security service; it is therefore imperative that when such bodies are set up, that they are seen to be above reproach; to be impartial. To quote an oft used phrase: in such cases justice must be seen, to be done.

Already some Opposition parliamentarians have dismissed the tribunal as a trio of BDP functionaries. This means whatever they do, their acts will be viewed though the political prism.

The image of this country to the outside world is partly dependent on how seriously we view the [continue reading]

source: IOL
November 29 2008 at 12:57PM
By Esther Lewis and Melanie Peters

In a major coup for South African medicine, clinical tests on two locally developed HIV vaccines will start in the US next week.

The South African Aids Vaccine Initiative (Saavi) announced on Friday that it had received the green light from the Medicines Control Council for the first locally developed HIV/Aids vaccine candidates to undergo human trials in Boston.

The two candidates have already been approved by the US Food and Drug Administration.

The initiative is a lead programme of the Medical Research Council and the medical field was abuzz with the news of the approval this week.

Elise Levendal, Saavi’s interim director, said she was “shaking with excitement”.

She said it was significant that this would be the first time that a vaccine developed in Africa would be tested in human trials in a first world country.

Generally, vaccines were developed in the US and [continue reading]